Live feed
Filing
SC 13D/A
SC 13D/A0000935836-23-000718·Logos Global Management LP
Schedule 13D ownership disclosure
Olema Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 60862P106
Event date: 2023-09-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,252,005
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-23-000718
- Form type
- SC 13D/A
- Filer
- Logos Global Management LP
- CIK
- CIK 1792126
- Filed
- Nov 28, 2023
- Reporting period
- Sep 12, 2023
- Description
- Schedule 13D beneficial ownership